Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEVRH4)

• Drug Name: 5BrUTP Drug Info
• Synonyms: 5-bromouridine triphosphate; bromouridine 5'-triphosphate; 5-bromo-UTP

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 9872620
  ChEBI ID: CHEBI:88358
  CAS Number: CAS 3398-50-3
  TTD Drug ID: DMEVRH4

Molecule-Related Drug Atlas

Drug(s) Targeting P2Y purinoceptor 6 (P2RY6)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
GC021109	DMQBEYV	Alzheimer disease	8A20	Phase 1	[4]
INS 316	DMTHMEI	Lung cancer	2C25.0	Discontinued in Phase 3	[3]
adenosine diphosphate	DMFUHKP	N. A.	N. A.	Investigative	[3]
2MeSATP	DMUE0W6	Discovery agent	N.A.	Investigative	[3]
RB 2	DMCEFUW	Discovery agent	N.A.	Investigative	[5]
PSB-0952	DMW19LB	Discovery agent	N.A.	Investigative	[5]
MRS2782	DMZSO4R	Discovery agent	N.A.	Investigative	[6]
MRS2578	DMKMPS6	Discovery agent	N.A.	Investigative	[7]
UDP-beta-S	DMMWHAV	Discovery agent	N.A.	Investigative	[8]
Up3U	DMKQWSB	Discovery agent	N.A.	Investigative	[8]

Drug(s) Targeting P2Y purinoceptor 2 (P2RY2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Diquafosol	DM64QG9	Dry eye disease	9E1Z	Phase 3	[9]
INS-37217	DMF93RQ	Cystic fibrosis	CA25	Phase 2	[9]
INS 316	DMTHMEI	Lung cancer	2C25.0	Discontinued in Phase 3	[10]
PSB-0963	DMBDVJ1	Discovery agent	N.A.	Investigative	[5]
RB 2	DMCEFUW	Discovery agent	N.A.	Investigative	[11]
UTPgammaS	DMKLB4O	Discovery agent	N.A.	Investigative	[2]
Acid blue 25	DMCU6XV	Discovery agent	N.A.	Investigative	[5]
2-thioUTP	DMJZ5V0	Discovery agent	N.A.	Investigative	[12]
SB-416	DMJW72O	Discovery agent	N.A.	Investigative	[11]
MDT-006	DMSF4UI	Constipation	DD91.1	Investigative	[13]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
P2Y purinoceptor 2 (P2RY2)	TTOZHQC	P2RY2_HUMAN	Agonist	[2]
P2Y purinoceptor 6 (P2RY6)	TTNVSKA	P2RY6_HUMAN	Agonist	[3]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1731).
• [2] Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol. 1995 Sep;116(1):1619-27.
• [3] Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun. 1996 May 15;222(2):303-8.
• [4] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [5] Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. J Med Chem. 2010 Mar 11;53(5):2076-86.
• [6] Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists. Bioorg Med Chem. 2008 Jun 15;16(12):6319-32.
• [7] Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol. 2004 May 1;67(9):1763-70.
• [8] P2 receptors activated by uracil nucleotides--an update. Curr Med Chem. 2006;13(3):289-312.
• [9] Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
• [10] Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Pediatr Pulmonol. 2001 Aug;32(2):122-8.
• [11] Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. Bioorg Med Chem Lett. 2008 Jan 1;18(1):223-7.
• [12] Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors. J Med Chem. 2006 Nov 30;49(24):7076-87.
• [13] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 324).